We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

17 hedge funds and large institutions have $1.33M invested in Protara Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

13% more funds holding

Funds holding: 15 → 17 (+2)

0.05% more ownership

Funds ownership: 0.6% → 0.65% (+0.05%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

32% less capital invested

Capital invested by funds: $1.96M → $1.33M (-$636K)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
3
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
+$32.3K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.2K
3
Renaissance Technologies
Renaissance Technologies
New York
+$23.1K
4
WS
Wedbush Securities
California
+$22.4K
5
BFM
Boothbay Fund Management
New York
+$20.6K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$17K
2
RJFSA
Raymond James Financial Services Advisors
Florida
-$5K
3
Jane Street
Jane Street
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$525K – – –
DM
2
Deerfield Management
New York
$318K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$200K +$23.1K +1,613 +9%
DVC
4
Deer VII & Co
New York
$82K – – –
WS
5
Wedbush Securities
California
$43K +$22.4K +1,562 +60%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$40K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$23K – – –
VF
8
Virtu Financial
New York
$23K +$32.3K +2,259 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$20K +$27.2K +1,901 New
BFM
10
Boothbay Fund Management
New York
$15K +$20.6K +1,440 New
OM
11
Opaleye Management
Massachusetts
$14K +$19.3K +1,350 New
UBS Group
12
UBS Group
Switzerland
$8K +$11.5K +800 New
Creative Planning
13
Creative Planning
Kansas
$6K +$8.7K +608 New
Northern Trust
14
Northern Trust
Illinois
$5K – – –
PAM
15
PVG Asset Management
Colorado
$2.6K +$3.58K +250 New
BlackRock
16
BlackRock
New York
$2K +$143 +10 +7%
Victory Capital Management
17
Victory Capital Management
Texas
$1K +$816 +57 New
Citadel Advisors
18
Citadel Advisors
Florida
– -$17K -1,051 Closed
RJFSA
19
Raymond James Financial Services Advisors
Florida
– -$5K -288 Closed
Jane Street
20
Jane Street
New York
– -$4K -258 Closed

TARA Hedge Fund Activity: Q3 2019 in Review

17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2019, worth a combined $1.33M — down 32% from $1.96M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TARA positions and 6 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $32.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $17K sold.

  • 17 institutional investors held Protara Therapeutics (TARA) as of Q3 2019, up from 15 in Q2 2019.
  • Funds reported $1.33M of Protara Therapeutics stock for Q3 2019, down 32% quarter-over-quarter.
  • 8 funds opened new Protara Therapeutics positions in Q3 2019 and 6 closed out, a net change of +2 holders.
  • The largest Protara Therapeutics buyer in Q3 2019 was Virtu Financial, an estimated $32.3K added.
  • The largest Protara Therapeutics seller in Q3 2019 was Citadel Advisors, an estimated $17K sold.

Based on aggregated 13F filings for Q3 2019.